CannTrust Holdings Inc (NYSE:CTST) Receives C$3.50 Consensus Target Price from Analysts
Shares of CannTrust Holdings Inc (NYSE:CTST) have earned an average rating of “Hold” from the ten analysts that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is C$3.50.
Several equities analysts have commented on the stock. ValuEngine lowered shares of CannTrust from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Zacks Investment Research raised shares of CannTrust from a “hold” rating to a “buy” rating and set a $0.50 target price on the stock in a report on Tuesday, March 10th.
NYSE:CTST opened at C$0.64 on Thursday. CannTrust has a 52 week low of C$0.38 and a 52 week high of C$8.17. The firm has a market cap of $90.27 million, a price-to-earnings ratio of -5.80 and a beta of 2.08. The firm’s 50-day simple moving average is C$0.64 and its 200 day simple moving average is C$0.83.
CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.
Featured Story: What is the outlook for the FAANG stocks?
Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.